share_log

津药药业(600488.SH):注射用甲泼尼龙琥珀酸钠通过一致性评价

Tianjin Tianyao Pharmaceuticals (600488.SH): Consistency evaluation passed for injection methylprednisolone succinate.

Zhitong Finance ·  Jul 22 04:01

Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, Tianjin Tianyao Heping Pharmaceutical Co., Ltd. (referred to as 'Tianyao Heping'), received the Supplementary Approval Notice for Injection Methylprednisolone Sodium Succinate (20mg) issued by the National Medical Products Administration. The drug has been approved for consistency evaluation of generic drug quality and efficacy. Injection Methylprednisolone Sodium Succinate is a glucocorticoid drug mainly used for anti-inflammatory treatment, immunosuppressive treatment, treatment of blood diseases and tumors, treatment of shock, etc.

Tianjin Tianyao Pharmaceuticals (600488.SH) announced that its subsidiary, Tianjin Tianyao Heping Pharmaceutical Co., Ltd. (referred to as 'Tianyao Heping'), received the Supplementary Approval Notice for Injection Methylprednisolone Sodium Succinate (20mg) issued by the National Medical Products Administration. The drug has been approved for consistency evaluation of generic drug quality and efficacy. Injection Methylprednisolone Sodium Succinate is a glucocorticoid drug mainly used for anti-inflammatory treatment, immunosuppressive treatment, treatment of blood diseases and tumors, treatment of shock, etc.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment